Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionDual-acting mu opioid agonist/NMDA antagonist
Molecular Target Mu opioid receptor (MOR) (OPRM1) ; NMDA receptor
Mechanism of ActionMu opioid receptor agonist; NMDA receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today